The COVID-19 pandemic has magnified systemic failures across health care locally and globally—from depleted public health infrastructures, fragmented delivery systems, and unacceptable outcome disparities. Ariadne Labs has been focused on developing evidence-based solutions to support clinicians, patients, the general public, and public health decision-makers. Our COVID-19 response builds on our core strengths—the ability to quickly convene, converge, and gather best ideas and practices; design and test guidelines and tools; and then strategically disseminate them as widely as possible through the many channels available to us.
Focus Areas
Supporting systems to deliver vaccines with speed, scale, and equity as supply and demand shift over time.
LEARN MOREFocusing on communicating simple, easy to use information for the general public to mitigate the exposure and spread of COVID-19.
LEARN MOREA global response can aid in ensuring equitable, efficient COVID-19 responses.
LEARN MOREInnovating around the impacts of COVID-19 on obstetric services from prenatal, labor and delivery, and postnatal care.
LEARN MOREResources for patients and providers to offer guidance and best practices to ensure safe, effective outpatient care.
LEARN MOREResources to help health systems and providers navigate the impact of COVID-19 to ensure the safety of patients and the health care workforce.
LEARN MORETools and resources for adults over the age of 65 and those with pre-existing health risks who at higher risk of severe illness from COVID-19.
LEARN MOREHighlights
The Harvard Gazette covers recent research from our Home Hospital team.
Dr. David Levine joins CareTalk w/ Quick and Quack where Drs Evan Benjamin and Bill Cutler interview him on his work implementing and researching Home Hospital programs.
Primary Health Care Fellow, Madeline Pesec, MD, ScM, co-authors new research finding that in areas where Costa Rica opened primary care health centers offering improved and expanded care, the mortality rate fell by 13% over a nine-year period.